107 related articles for article (PubMed ID: 17369084)
1. Melatonin treatment efficacy: for whom and for what?
Van Someren EJ
Sleep Med; 2007 Apr; 8(3):193-5. PubMed ID: 17369084
[No Abstract] [Full Text] [Related]
2. Endogenous melatonin predicts efficacy of exogenous melatonin in consolidation of fragmented wrist-activity rhythm of adult patients with developmental brain disorders: a double-blind, placebo-controlled, crossover study.
Laakso ML; Lindblom N; Leinonen L; Kaski M
Sleep Med; 2007 Apr; 8(3):222-39. PubMed ID: 17368097
[TBL] [Abstract][Full Text] [Related]
3. Melatonin treatment for circadian rhythm sleep disorders.
Kamei Y; Hayakawa T; Urata J; Uchiyama M; Shibui K; Kim K; Kudo Y; Okawa M
Psychiatry Clin Neurosci; 2000 Jun; 54(3):381-2. PubMed ID: 11186123
[TBL] [Abstract][Full Text] [Related]
4. Effects of exogenous melatonin on sleep: a meta-analysis.
Brzezinski A; Vangel MG; Wurtman RJ; Norrie G; Zhdanova I; Ben-Shushan A; Ford I
Sleep Med Rev; 2005 Feb; 9(1):41-50. PubMed ID: 15649737
[TBL] [Abstract][Full Text] [Related]
5. The use of melatonin to treat sleep disorder in adults with intellectual disabilities in community settings - the evaluation of three cases using actigraphy.
Dodd A; Hare DJ; Arshad P
J Intellect Disabil Res; 2008 Jun; 52(Pt 6):547-53. PubMed ID: 18444986
[TBL] [Abstract][Full Text] [Related]
6. Effect of melatonin on sleep-wake rhythm: the sleep diary of an autistic male.
Hayashi E
Psychiatry Clin Neurosci; 2000 Jun; 54(3):383-4. PubMed ID: 11186124
[TBL] [Abstract][Full Text] [Related]
7. The role of melatonin in patients with chronic kidney disease undergoing haemodialysis.
Aperis G; Prakash P; Paliouras C; Papakonstantinou N; Alivanis P
J Ren Care; 2012 Jun; 38(2):86-92. PubMed ID: 22494522
[TBL] [Abstract][Full Text] [Related]
8. [Delayed wakefulness-sleep rhythm syndrome and melatonin. Synthesis of existing studies].
Quera Salva MA; Lainey E; Léger D; Santos C; Billiard M
Rev Neurol (Paris); 2001 Nov; 157(11 Pt 2):S126-9. PubMed ID: 11924024
[TBL] [Abstract][Full Text] [Related]
9. Melatonin treatment in adolescents with delayed sleep phase syndrome.
Szeinberg A; Borodkin K; Dagan Y
Clin Pediatr (Phila); 2006 Nov; 45(9):809-18. PubMed ID: 17041168
[TBL] [Abstract][Full Text] [Related]
10. Circadian rhythm sleep disorders in the blind and their treatment with melatonin.
Skene DJ; Arendt J
Sleep Med; 2007 Sep; 8(6):651-5. PubMed ID: 17420154
[TBL] [Abstract][Full Text] [Related]
11. Melatonin and sleep disorders associated with intellectual disability: a clinical review.
Sajith SG; Clarke D
J Intellect Disabil Res; 2007 Jan; 51(Pt 1):2-13. PubMed ID: 17181598
[TBL] [Abstract][Full Text] [Related]
12. Behavioral effects of melatonin treatment in non-human primates.
Zhdanova IV; Cantor ML; Leclair OU; Kartashov AI; Wurtman RJ
Sleep Res Online; 1998; 1(3):114-8. PubMed ID: 11382867
[TBL] [Abstract][Full Text] [Related]
13. Tasimelteon, a melatonin agonist for the treatment of insomnia and circadian rhythm sleep disorders.
Hardeland R
Curr Opin Investig Drugs; 2009 Jul; 10(7):691-701. PubMed ID: 19579175
[TBL] [Abstract][Full Text] [Related]
14. A randomized, placebo-controlled trial of controlled release melatonin treatment of delayed sleep phase syndrome and impaired sleep maintenance in children with neurodevelopmental disabilities.
Wasdell MB; Jan JE; Bomben MM; Freeman RD; Rietveld WJ; Tai J; Hamilton D; Weiss MD
J Pineal Res; 2008 Jan; 44(1):57-64. PubMed ID: 18078449
[TBL] [Abstract][Full Text] [Related]
15. [Circadian rhythm sleep disorders].
Pallesen S; Bjorvatn B
Tidsskr Nor Laegeforen; 2009 Sep; 129(18):1884-7. PubMed ID: 19844284
[TBL] [Abstract][Full Text] [Related]
16. [Melatonin treatment of sleep disorders in disabled children].
Ramstad K; Loge JH
Tidsskr Nor Laegeforen; 2002 Apr; 122(10):1009-11. PubMed ID: 12082692
[TBL] [Abstract][Full Text] [Related]
17. [Melatonin in delayed sleep phase disorder--why licensed?].
Eckerberg B
Lakartidningen; 2008 Sep 3-9; 105(36):2429-30. PubMed ID: 18831457
[No Abstract] [Full Text] [Related]
18. Smith-Magenis syndrome: a case report of improved sleep after treatment with beta1-adrenergic antagonists and melatonin.
Carpizo R; Martínez A; Mediavilla D; González M; Abad A; Sánchez-Barceló EJ
J Pediatr; 2006 Sep; 149(3):409-11. PubMed ID: 16939758
[TBL] [Abstract][Full Text] [Related]
19. Long-term effectiveness outcome of melatonin therapy in children with treatment-resistant circadian rhythm sleep disorders.
Carr R; Wasdell MB; Hamilton D; Weiss MD; Freeman RD; Tai J; Rietveld WJ; Jan JE
J Pineal Res; 2007 Nov; 43(4):351-9. PubMed ID: 17910603
[TBL] [Abstract][Full Text] [Related]
20. Ramelteon: a novel treatment for the treatment of insomnia.
Wurtman R
Expert Rev Neurother; 2006 Jul; 6(7):957-64. PubMed ID: 16831111
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
